Follow
Yujie Zhao
Yujie Zhao
Verified email at merck.com - Homepage
Title
Cited by
Cited by
Year
Rapid detection of hot-spots via tensor decomposition with applications to crime rate data
Y Zhao, H Yan, S Holte, Y Mei
Journal of Applied Statistics 49 (7), 1636-1662, 2022
112022
Rapid detection of hot-spot by tensor decomposition with application to weekly gonorrhea data
Y Zhao, H Yan, SE Holte, RP Kerani, Y Mei
International Workshop on Intelligent Statistical Quality Control, 265-286, 2019
82019
Impact of molnupiravir treatment on patient-reported coronavirus disease 2019 (COVID-19) symptoms in the Phase 3 MOVe-OUT trial: A randomized, placebo-controlled trial
Y Guan, A Puenpatom, MG Johnson, Y Zhang, Y Zhao, J Surber, ...
Clin. Infect. Dis, 2023
7*2023
A survey of numerical algorithms that can solve the Lasso problems
Y Zhao, X Huo
Wiley Interdisciplinary Reviews: Computational Statistics, e1602, 2022
72022
Identification of underlying dynamic system from noisy data with splines
Y Zhao, X Huo, Y Mei
arXiv preprint arXiv:2103.10231, 2021
42021
Accelerate the warm-up stage in the Lasso computation via a homotopic approach
Y Zhao, X Huo
Computational Statistics & Data Analysis 184, 107747, 2023
3*2023
Hot-spots detection in count data by Poisson assisted smooth sparse tensor decomposition
Y Zhao, H Xiaoming, M Yajun
Journal of Applied Statistics, 1-31, 2022
32022
New progress in hot-spots detection, partial-differential-equation-based model identification and statistical computation
Y Zhao
Georgia Institute of Technology, 2021
22021
Number of Repetitions in Re-randomization Tests
Y Zhang, Y Zhao, Y Luo
arXiv preprint arXiv:2302.05977, 2023
12023
Electronic common technical document submission with analysis using R
Y Zhao, N Xiao, K Anderson, Y Zhang
Clinical Trials 20 (1), 89-92, 2023
12023
Some group sequential trials from industry over the last 30 years
KM Anderson, Y Zhao, N Xiao, J Ge, HF Weisman
Statistics in Biopharmaceutical Research, 1-13, 2024
2024
Sodium Glucose Co-transporter 2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis
SM Patel, YM Kang, KA Im, BL Neuen, SD Anker, DL Bhatt, J Butler, ...
Circulation, 2024
2024
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma: Outcomes in histopathologic subgroups from the randomized, double-blind, phase 3 KEYNOTE …
D Schadendorf, JJ Luke, PA Ascierto, GV Long, P Rutkowski, A Khattak, ...
Journal for Immunotherapy of Cancer 12 (3), 2024
2024
Group Sequential Design Under Non-proportional Hazards
Y Zhao, Y Zhang, L Leon, KM Anderson
arXiv preprint arXiv:2312.01723, 2023
2023
Adjusted inference for multiple testing procedure in group sequential designs
Y Zhao, Q Liu, LZ Sun, KM Anderson
arXiv preprint arXiv:2311.15498, 2023
2023
76P Safety profile of adjuvant pembrolizumab (pembro) in melanoma, non-small cell lung cancer (NSCLC), and renal cell carcinoma (RCC): Pooled analysis of phase III clinical trials
JJ Luke, GV Long, C Robert, MS Carlino, TK Choueiri, NB Haas, ...
Immuno-Oncology and Technology 16, 2022
2022
The appreciation of statistical thoughts
Y Zhao
Statistical Theory and Related Fields 3 (1), 83-84, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–17